Two Sigma Advisers
BIVV

Two Sigma Advisers’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Two Sigma Advisers’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-913,778
Closed -$49.3M – 2497
2017
Q4 		$49.3M Sell
913,778
-122,274
-12% -$6.69M 0.13% 199
2017
Q3 		$59.1M Sell
1,036,052
-249,218
-19% -$14.6M 0.17% 153
2017
Q2 		$77.3M Buy
1,285,270
+77,157
+6% +$4.39M 0.26% 95
2017
Q1 		$65.8M Buy
+1,208,113
New +$59.5M 0.22% 113

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Two Sigma Advisers's BIVV Position: Q1 2018 in Review

Two Sigma Advisers sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 913,778 shares — an estimated $49.3M sold.

Two Sigma Advisers first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $77.3M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Two Sigma Advisers reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Two Sigma Advisers sold 913,778 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $49.3M.
  • Two Sigma Advisers first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Two Sigma Advisers's Bioverativ Inc. Common Stock position peaked at $77.3M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Two Sigma Advisers's 13F filing for Q1 2018, filed 15 May 2018.